Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research focused on Parkinson's disease and Apolipoprotein E, with related work in Odds ratio, TREM2, Progressive supranuclear palsy. Notable publications include 'The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease', 'Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease', and 'GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study'.
<scp><i>GBA</i></scp> and <scp><i>APOE</i></scp> Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study
Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
Combinatory microRNA serum signatures as classifiers of Parkinson's disease
Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden
The role of <i>TREM2</i> R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study
Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease